Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRASTUZUMAB EMTANSINE vs TREMELIMUMAB\TREMELIMUMAB-ACTL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRASTUZUMAB EMTANSINE vs TREMELIMUMAB\TREMELIMUMAB-ACTL: Safety Overview

Metric TRASTUZUMAB EMTANSINE TREMELIMUMAB\TREMELIMUMAB-ACTL
Total FAERS Reports 183 1,173
Deaths Reported 21 328
Death Rate 11.5% 28.0%
Hospitalizations 119 428
Average Patient Age 55.3 yrs 71.1 yrs
% Female Patients 97.4% 18.5%
Manufacturer Genentech, Inc. N/A
Route INTRAVENOUS N/A